GKB Ophthalmics Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹95.75
- Today's High:
- ₹108.7
- Open Price:
- ₹106.12
- 52W Low:
- ₹80
- 52W High:
- ₹197.9
- Prev. Close:
- ₹105.28
- Volume:
- 7906
Company Statistics
- Market Cap.:
- ₹307.73 million
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
GKB Ophthalmics Limited had its IPO on under the ticker symbol 533212.
The company operates in the Other sector and Other industry. GKB Ophthalmics Limited has a staff strength of 0 employees.
Stock update
Shares of GKB Ophthalmics Limited opened at ₹106.12 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹95.75 - ₹108.7, and closed at ₹97.4.
This is a -7.48% slip from the previous day's closing price.
A total volume of 7,906 shares were traded at the close of the day’s session.
In the last one week, shares of GKB Ophthalmics Limited have increased by +3.88%.
GKB Ophthalmics Limited's Key Ratios
GKB Ophthalmics Limited has a market cap of ₹307.73 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months GKB Ophthalmics Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures GKB Ophthalmics Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, GKB Ophthalmics Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, GKB Ophthalmics Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
GKB Ophthalmics Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into GKB Ophthalmics Limited’s profitability.
GKB Ophthalmics Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
GKB Ophthalmics Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.12 billion
- Total Liabilities
- ₹412.69 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
GKB Ophthalmics Limited ended 2024 with ₹1.12 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.12 billion while shareholder equity stood at ₹626.93 million.
GKB Ophthalmics Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹412.69 million in other current liabilities, 50406000.00 in common stock, ₹576.53 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹23.64 million and cash and short-term investments were ₹40.20 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹11.70 million.
GKB Ophthalmics Limited’s total current assets stands at ₹835.31 million while long-term investments were ₹0 and short-term investments were ₹16.56 million. Its net receivables were ₹277.39 million compared to accounts payable of ₹237.94 million and inventory worth ₹387.40 million.
In 2024, GKB Ophthalmics Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, GKB Ophthalmics Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹97.4
- 52-Week High
- ₹197.9
- 52-Week Low
- ₹80
- Analyst Target Price
- ₹
GKB Ophthalmics Limited stock is currently trading at ₹97.4 per share. It touched a 52-week high of ₹197.9 and a 52-week low of ₹197.9. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹89.4 and 200-day moving average was ₹110.26 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.